Susquehanna Fundamental Investments’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.43M | Hold |
33,097
| – | – | 0.07% | 302 |
|
|
2025
Q1 | $3.78M | Hold |
33,097
| – | – | 0.05% | 380 |
|
|
2024
Q4 | $1.67M | Buy |
+33,097
| New | +$1.67M | 0.02% | 576 |
|
|
2024
Q2 | – | Sell |
-14,740
| Closed | -$371K | – | 944 |
|
|
2024
Q1 | $371K | Buy |
+14,740
| New | +$371K | 0.02% | 512 |
|
|
2021
Q4 | – | Sell |
-52,389
| Closed | -$1.03M | – | 1494 |
|
|
2021
Q3 | $1.03M | Buy |
52,389
+29,189
| +126% | +$574K | 0.02% | 844 |
|
|
2021
Q2 | $510K | Sell |
23,200
-20,652
| -47% | -$454K | 0.01% | 1158 |
|
|
2021
Q1 | $1.04M | Buy |
43,852
+475
| +1% | +$11.3K | 0.02% | 870 |
|
|
2020
Q4 | $1.14M | Buy |
43,377
+18,577
| +75% | +$486K | 0.02% | 827 |
|
|
2020
Q3 | $432K | Buy |
+24,800
| New | +$432K | 0.01% | 930 |
|